Literature DB >> 18674688

The detectability and localization accuracy of implanted fiducial markers determined on in-room computerized tomography (CT) and electronic portal images (EPI).

Rebecca Owen1, Tomas Kron, Farshad Foroudi, Jennifer Cox, Li Zhu, Jim Cramb, Laura Sparks, Gillian Duchesne.   

Abstract

Many different methods of image guidance are available for radiotherapy treatment (IGRT). The aims of the study were (1) to determine the optimal diameter of gold markers for IGRT to the prostate; (2) to compare, using the Siemens Primatom, the relative merits of in-room computerized tomography (CT) and electronic portal image (EPI) for locating the marker seeds. Gold markers of differing widths were embedded in 2 phantoms (perspex slabs and anthropomorphic). Images were acquired with an amorphous silicon flat panel detector (Siemens Optivue 500) and with the in-room CT scanner (Siemens Somatom Balance). The EPIs were reviewed independently by 6 operators to determine which diameter marker could be best visualized. The optimal marker technique was determined by comparing the investigators' observed marker co-ordinates with the known locations within the phantom. The visibility of all markers on anterior-posterior EPIs was 100%. On the lateral EPI, of a possible 180 visualizations of 1.2-, 1.0-, and 0.8-mm diameter markers, 176 (97.8%), 151 (83.9%), and 132 (73.3%), respectively, were successful. On EPI, the average deviation of fiducial markers from the known position was less than 0.5 mm in any direction. On CT, the largest deviation (2.17 mm) of markers from the known coordinate position was in the superior-inferior direction, reflecting the 3.0-mm slice thickness used. EPI accurately located internal markers in all dimensions. The availability of "gold standard" CT imagery at the treatment unit does not improve how accurately the position of markers in a phantom can be defined compared with EPI. However, CT imagery does provide important soft tissue information, the benefits of which are being investigated further.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18674688     DOI: 10.1016/j.meddos.2007.12.002

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  4 in total

1.  Numerical deconvolution to enhance sharpness and contrast of portal images for radiotherapy patient positioning verification.

Authors:  H K Looe; Y Uphoff; D Harder; B Poppe; K C Willborn
Journal:  Strahlenther Onkol       Date:  2012-01-12       Impact factor: 3.621

2.  Electronic portal imaging vs kilovoltage imaging in fiducial marker image-guided radiotherapy for prostate cancer: an analysis of set-up uncertainties.

Authors:  S Gill; J Thomas; C Fox; T Kron; A Thompson; S Chander; S Williams; K H Tai; G Duchesne; F Foroudi
Journal:  Br J Radiol       Date:  2011-10-05       Impact factor: 3.039

3.  Calcium Phosphate Cement Paste Injection as a Fiducial Marker of Cervical Cancer.

Authors:  Ichiro Ogino; Masakazu Kitagawa; Shigenobu Watanabe; Hiroshi Yoshida; Masaharu Hata
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

4.  Gold marker displacement due to needle insertion during HDR-brachytherapy for treatment of prostate cancer: a prospective cone beam computed tomography and kilovoltage on-board imaging (kV-OBI) study.

Authors:  Markus K A Herrmann; Tereza Kertesz; Tammo Gsänger; Eugen Bloch; Gerhard Pollul; Mohamed Bouabdallaoui; Arne Strauss; Mareike Herrmann; Hans Christiansen; Hendrik A Wolff; Clemens F Hess; Andrea Hille
Journal:  Radiat Oncol       Date:  2012-02-20       Impact factor: 3.481

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.